The use of FAP-specific chimeric antigen receptor T-cell therapy has been reported to be able to eliminate most FAP positive CAFs and decrease tumour stromal generation; however, significant side effects were observed, especially with respect to bone marrow toxicity [181]. Here, FAP is linked to neoplasm.